Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 147

Sort by

Sort Order Select

Journal Articles

Therapeutic preclinical study on the synergy between CD73 inhibitors and selinexor for managing multiple myeloma

Chun-Li Zhang, Qiuxia Wei, Nigmat Rahim, Gang Bian, Chaoling Wu, Jing Wang, Ping Yang, Jiahui Hua, Mingxia Zhu, Yingtong Chen, Yan Liu, Shuang Gao, Bing Hou, Weilong Zhang, Hongmei Jing

Blood (2025) 146 (Supplement 1): 7455.

https://doi.org/10.1182/blood-2025-7455

Published: 2025

Journal Articles

Prognostic and therapeutic implications of the immune landscape in Mantle Cell Lymphoma

Changjian Yan, Chaoling Wu, Ping Yang, Xiaoyu Hao, Jie Chen, Jing Wang, Mingxia Zhu, Yan Liu, Hongmei Jing, Weilong Zhang

Blood (2025) 146 (Supplement 1): 1821.

https://doi.org/10.1182/blood-2025-1821

Published: 2025

Journal Articles

ICAM-2 mediates adhesion of acute myeloid leukemia cells to bone marrow microenvironment and promotes chemoresistance

Xinqi Li, Muheremu Muhetaer, Jin xian Liu, Xiao yan Liu, Fuling Zhou

Blood (2025) 146 (Supplement 1): 1691.

https://doi.org/10.1182/blood-2025-1691

Published: 2025

Journal Articles

Genomic characterization uncovers molecular subtypes in Mantle Cell Lymphoma

Changjian Yan, Ping Yang, Jie Chen, Chaoling Wu, Xiaoyu Hao, Jing Wang, Mingxia Zhu, Yan Liu, Weilong Zhang, Hongmei Jing

Blood (2025) 146 (Supplement 1): 3590.

https://doi.org/10.1182/blood-2025-3590

Published: 2025

Journal Articles

Efficacy and safety of pegylated interferon alfa-2b in myeloproliferative neoplasms: A multicenter retrospective study of 210 patients

Qing Leng, Yueyue Zheng, Junqing Xu, Daohua Ning, Dexiao Kong, Guozhen Liu, Jie Yu, Hongguo Zhao, Xianghua Wang, Haiguo Zhang, Yan Liu, Qingli Ji, Chen Chunyan

Blood (2025) 146 (Supplement 1): 7336.

https://doi.org/10.1182/blood-2025-7336

Published: 2025

Journal Articles

Blinatumomab following reduced-intensity induction chemotherapy in Chinese children with intermediate- or high-risk B-cell precursor acute lymphoblastic leukemia

Blood (2025) 146 (Supplement 1): 5133.

https://doi.org/10.1182/blood-2025-5133

Published: 2025

Journal Articles

Efficacy and safety of iptacopan in Chinese patients with paroxysmal nocturnal hemoglobinuria: A multicenter retrospective study

Xiaoqing Li, Zhilong Xu, Yan Guo, Ran Wang, Yan Liu, Qiang Song, Guosheng Li, Xiaolin Zhang, Qingli Ji, Xinwen Jiang, Sai Ma, Minran Zhou, Chen Chunyan

Blood (2025) 146 (Supplement 1): 2893.

https://doi.org/10.1182/blood-2025-2893

Published: 2025

Journal Articles

Global Burden of Disease of Multiple Myeloma in China from 1990 to 2021

Guixiang Duan, Xuelin Dou, Yanting Zhong, Kai-Yan Liu, Jinlei Qi, Jin Lu, Maigeng Zhou

Blood (2024) 144 (Supplement 1): 6974.

https://doi.org/10.1182/blood-2024-205159

Published: 2024

Journal Articles

CBL Loss or Mutations Reduces MHCII Expression through Downregulating ERG in Myeloid Malignancies

Rouxing Wang, Mohammed Alhusayan, Bowen Xing, Emma Hedgepeth, Yan Liu, Hamid Band, Laurence Eisenlohr, Junwei Shi, Irfan Asangani, Wei Tong

Blood (2024) 144 (Supplement 1): 2730.

https://doi.org/10.1182/blood-2024-208798

Published: 2024

Journal Articles

Time-Limited of Zanubrutinib, Rituximab and Lenalidomide (ZR2) Regimen for the Treatment of Super-Elderly Diffuse Large B-Cell Lymphoma (DLBCL): A Prospective, Exploratory Clinical Study

Jie Zou, Xiaoning Yu, Xiaoxia Chu, Ji Ma, Zengjun Li, Chunyan Chen, Yan Liu, Jian Xing, Zhongliang Sun, Chunyan Ji, Jie Li

Blood (2024) 144 (Supplement 1): 1732.

https://doi.org/10.1182/blood-2024-207021

Published: 2024

Journal Articles

Protein Tyrosine Phosphatase PRL2 Promotes MLL -Rearranged Acute Myeloid Leukemia Development through Inhibiting the p53 Pathway

Shiyu Xiao, Hongxia Chen, Michihiro Kobayashi, Yunpeng Bai, Sergio Barajas, Wenjie Cai, Zhong-Yin Zhang, Yan Liu

Blood (2024) 144 (Supplement 1): 4109.

https://doi.org/10.1182/blood-2024-198244

Published: 2024

Journal Articles

Myelodysplastic Syndrome Stem Cells Evaluated By Multiparameter Flow Cytometry Are Associated with Posttreatment Relapse: A Prospective Study

Wei-Bin Wu, Ya-Wen Luo, Siqi Li, Lanping Xu, Yu Wang, Xiaohui Zhang, Yuqian Sun, Feifei Tang, Xiaodong Mo, Kai-Yan Liu, Xiao-Su Zhao, Xiang-Yu Zhao, He-Bing Chen, Ying-Jun Chang, Xiaojun Huang

Blood (2024) 144 (Supplement 1): 1834.

https://doi.org/10.1182/blood-2024-207920

Published: 2024

Journal Articles

Molecular Measurable Residual Disease before Transplantation Independently Predicts Survival and Relapse Risk in Adult KMT2A-Rearranged Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 2938.

https://doi.org/10.1182/blood-2024-204843

Published: 2024

Journal Articles

Exploring Treatment-Driven Subclonal Evolution of Prognostic and Predictive Triple Biomarkers: Dual Gene Fusions and Chimeric RNA Variants in Subtypes of Acute Myeloid Leukemia Patients with KMT2A Rearrangement

Blood (2024) 144 (Supplement 1): 6099.

https://doi.org/10.1182/blood-2024-204217

Published: 2024

Journal Articles

CBL Loss or Mutations Upregulates AXL to Promote Cytokine-Independent Growth in Myeloid Malignancies: AXL Upregulation Promotes Cytokine-Independent Growth in CBL -Mutant CMML

Rouxing Wang, Shiwei Chen, Mohammed Alhusayan, Bowen Xing, Yan Liu, Hamid Band, Irfan Asangani, Junwei Shi, Wei Tong

Blood (2024) 144 (Supplement 1): 4574.

https://doi.org/10.1182/blood-2024-209140

Published: 2024

Journal Articles

The Combination of Intravenous Immunoglobulin (IVIG) and Low Does Recombinant Human Thrombopoietin (rhTPO) for the Management of Corticosteroid/IVIG Monotherapy-Resistant Immune Thrombocytopenia in Pregnancy

Yun He, Haixia Fu, Xiaolu Zhu, Qiusha Huang, Qi Chen, Jin Wu, Yuxiu Chen, Peng Zhao, Kai-Yan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 1213.

https://doi.org/10.1182/blood-2023-185453

Published: 2023

Journal Articles

Ixazomib Maintenance Therapy in Chinese Patients with Newly Diagnosed Multiple Myeloma Not Treated with Stem Cell Transplantation: A Single-Arm, Open-Label Study

Weijun Fu, Juan Du, Lu Zhong, Lijuan Chen, Jian Li, Donghua Zhang, Jianqing Mi, Yan Liu, Sheng Wu, Richard Labotka, Cong Li, Wenhan Jiang, Wenming Chen

Blood (2023) 142 (Supplement 1): 6735.

https://doi.org/10.1182/blood-2023-181444

Published: 2023

Journal Articles

Epcoritamab SC Monotherapy Leads to Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: First Data Disclosure from the Epcore NHL-1 Follicular Lymphoma Dose-Expansion Cohort

Blood (2023) 142 (Supplement 1): 1655.

https://doi.org/10.1182/blood-2023-179887

Published: 2023

Journal Articles

Polycom Group Protein Mel18 Inhibits Hematopoietic Stem Cell Self-Renewal through Repressing the Expression of Genes Important for Cellular Senescence and Proliferation

Wenjie Cai, Sisi Chen, Xicheng Liu, Xintong Chen, Sergio Barajas, Shiyu Xiao, Hongxia Chen, Rongwen Xi, Zhonghua Gao, Feng Yue, Yan Liu

Blood (2023) 142 (Supplement 1): 1310.

https://doi.org/10.1182/blood-2023-180201

Published: 2023

Journal Articles

Iguratimod Regulates CD4+ T-Cell Homeostasis and Function By Restoring PINK1/Parkin-Mediated Mitophagy in Immune Thrombocytopenia

Yuxiu Chen, Kai-Yan Liu, Haixia Fu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 279.

https://doi.org/10.1182/blood-2023-185876

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Therapeutic preclinical study on the synergy between CD73 inhibitors and selinexor for managing multiple myeloma

Prognostic and therapeutic implications of the immune landscape in Mantle Cell Lymphoma

ICAM-2 mediates adhesion of acute myeloid leukemia cells to bone marrow microenvironment and promotes chemoresistance

Genomic characterization uncovers molecular subtypes in Mantle Cell Lymphoma

Efficacy and safety of pegylated interferon alfa-2b in myeloproliferative neoplasms: A multicenter retrospective study of 210 patients

Blinatumomab following reduced-intensity induction chemotherapy in Chinese children with intermediate- or high-risk B-cell precursor acute lymphoblastic leukemia

Efficacy and safety of iptacopan in Chinese patients with paroxysmal nocturnal hemoglobinuria: A multicenter retrospective study

Global Burden of Disease of Multiple Myeloma in China from 1990 to 2021

CBL Loss or Mutations Reduces MHCII Expression through Downregulating ERG in Myeloid Malignancies

Time-Limited of Zanubrutinib, Rituximab and Lenalidomide (ZR2) Regimen for the Treatment of Super-Elderly Diffuse Large B-Cell Lymphoma (DLBCL): A Prospective, Exploratory Clinical Study

Protein Tyrosine Phosphatase PRL2 Promotes MLL -Rearranged Acute Myeloid Leukemia Development through Inhibiting the p53 Pathway

Myelodysplastic Syndrome Stem Cells Evaluated By Multiparameter Flow Cytometry Are Associated with Posttreatment Relapse: A Prospective Study

Molecular Measurable Residual Disease before Transplantation Independently Predicts Survival and Relapse Risk in Adult KMT2A-Rearranged Acute Myeloid Leukemia

Exploring Treatment-Driven Subclonal Evolution of Prognostic and Predictive Triple Biomarkers: Dual Gene Fusions and Chimeric RNA Variants in Subtypes of Acute Myeloid Leukemia Patients with KMT2A Rearrangement

CBL Loss or Mutations Upregulates AXL to Promote Cytokine-Independent Growth in Myeloid Malignancies: AXL Upregulation Promotes Cytokine-Independent Growth in CBL -Mutant CMML

The Combination of Intravenous Immunoglobulin (IVIG) and Low Does Recombinant Human Thrombopoietin (rhTPO) for the Management of Corticosteroid/IVIG Monotherapy-Resistant Immune Thrombocytopenia in Pregnancy

Ixazomib Maintenance Therapy in Chinese Patients with Newly Diagnosed Multiple Myeloma Not Treated with Stem Cell Transplantation: A Single-Arm, Open-Label Study

Epcoritamab SC Monotherapy Leads to Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: First Data Disclosure from the Epcore NHL-1 Follicular Lymphoma Dose-Expansion Cohort

Polycom Group Protein Mel18 Inhibits Hematopoietic Stem Cell Self-Renewal through Repressing the Expression of Genes Important for Cellular Senescence and Proliferation

Iguratimod Regulates CD4+ T-Cell Homeostasis and Function By Restoring PINK1/Parkin-Mediated Mitophagy in Immune Thrombocytopenia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only